TrialEuropean child & adolescent psychiatry2016

Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.

Peter Nagy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.